Caribou Biosciences (CRBU) Shares Outstanding (Diluted) (2021 - 2026)
Caribou Biosciences' Weighted Average Shares Outstanding (Diluted) was 100.99 million in Q2 2026, up 8.6% from 93.03 million a year earlier and up 5.3% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, Weighted Average Shares Outstanding (Diluted) at Caribou Biosciences came in at 93.39 million, up 3.4% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has now increased for four consecutive years, with a four-year compound annual growth rate of 31.0% (FY2021 to FY2025).
- In earlier years, Weighted Average Shares Outstanding (Diluted) was 90.32 million in FY2024 (+22.4%), 73.81 million in FY2023 (+21.4%), 60.8 million in FY2022 (+92.0%) and 31.66 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q2 2021.
- Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) has increased for 17 straight quarters, with growth averaging 7.0% over the last eight quarters.
- The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 1.1% (Q1 2023) and 492.1% (Q2 2022) over the last five years.
- Per Business Quant data, CRBU's Weighted Average Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 95.86 million (Q1 2026), 93.39 million (Q4 2025) and 93.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Caribou Biosciences | 44.30 Mn | -419.78 Mn | - | 107.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 107.54 Mn |
| Jun 30, 2026 | 100.99 Mn |
| Mar 31, 2026 | 95.86 Mn |
| Dec 31, 2025 | 93.39 Mn |
| Sep 30, 2025 | 93.29 Mn |
| Jun 30, 2025 | 93.03 Mn |
| Mar 31, 2025 | 92.68 Mn |
| Dec 31, 2024 | 90.32 Mn |
| Sep 30, 2024 | 90.46 Mn |
| Jun 30, 2024 | 90.34 Mn |
| Mar 31, 2024 | 89.30 Mn |
| Dec 31, 2023 | 73.81 Mn |
| Sep 30, 2023 | 83.78 Mn |
| Jun 30, 2023 | 61.42 Mn |
| Mar 31, 2023 | 61.19 Mn |
| Dec 31, 2022 | 60.80 Mn |
| Sep 30, 2022 | 60.89 Mn |
| Jun 30, 2022 | 60.76 Mn |
| Mar 31, 2022 | 60.55 Mn |
| Dec 31, 2021 | 31.66 Mn |
API Access
Caribou Biosciences Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();